Pfizer Inc., the world's biggest drug manufacturer, will introduce 20 news drugs to China in the next five years, said the company's vice-chairman Jeffrey Kindler here Wednesday.
Pfizer has introduced 40 types of drugs during its more than two decades of operation in China. Kindler said the introduction of new drugs epitomizes its long-term commitment towards developing the Chinese market.
Kindler, who attended the May 16-18 Fortune Global Forum, said that China has made much progress on intellectual property rights (IPR) protection, and efforts have to be made to build a transparent and consistent protection system.
He said he is optimistic about the company's appeal for protecting the patent on its erectile dysfunction drug, Viagra, since China has continued to improve its IPR protection.
The company is now appealing to the decision of China's State Intellectual Office to overturn its Chinese patent for Viagra.
Starting its China business in 1989, Pfizer has invested more than 500 million US dollars in China and set up production facilities in Dalian in northeast China, and Suzhou and Wuxi in east China.